|
1) Stout AP. Juvenile fibromatoses. Cancer. 1954;7:953-78.
|
|
|
|
|
2) Lazar AJ et al. Specific mutations in β-catenin gene (CTNNB1)correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008; 173:1518-27.
|
|
|
|
|
3) Reitamo JJ et al. The desmoid tumor.I.Incidence, sex-, age-, and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982;77:665-73.
|
|
|
|
|
|
4) 佐久間淳ほか.膵臓浸潤を認めた横行結腸間膜デスモイド腫瘍の1切除例.癌と化療.2020;47:71-5.
|
|
|
|
|
5) 古屋信二ほか.開腹歴のない結腸間膜原発デスモイド腫瘍の1例.日臨外会誌.2011;72:2420-4.
|
|
|
|
|
6) Martínez Trufero J et al. Desmoid-type fibromatosis:who, when, and how to treat. Curr Treat Options Oncol. 2017. doi:10.1007/s11864-017-6474-0.
|
|
|
|
|
|
7) Tejper S et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoids tumor). Oncogene. 1999;18:6615-20.
|
|
|
|
|
|
8) Montogomery E et al. Beta-catenin immunohistochemistry sepatrates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002;26:1296-301.
|
|
|
|
|
|
9) Crago AM et al. Prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 2013;258:347-53.
|
|
|
|
|
|
10) Smith AJ et al. Surgical management of intra-abdominal desmoid tumours. Br J Surg. 2000;87:608-13.
|
|
|
|
|
|
11) Clark SK et al. Desmoids in familial adenomatous polyposis. Br J Surg. 1996;83:1494-504.
|
|
|
|
|
|
12) Das Gupta TK et al. Extra-abdominal desmoids:a clinicopathological study. Ann Surg. 1969;170:109-12.
|
|
|
|
|
|
13) Posner MC et al. The desmoid tumor. Arch Surg. 1989;124:191-6.
|
|
|
|
|
|
14) 稲吉 厚ほか.横行結腸間膜より発生した腸間膜線維腫症の1例.日臨外会誌.2006;67:178-82.
|
|
|
|
|
|
15) 田中花林ほか.経過中に腸間膜巨大デスモイド腫瘍が発生しAPC遺伝子異常が確認された孤発性Gardner症候群の1症例.日大腸肛門病会誌.2010;63:419-25.
|
|
|
|
|
|
16) 伊藤宏之ほか.腸間膜デスモイド腫瘍の1例.日臨外会誌.1997;58:2439-43.
|
|
|
|
|
|
17) Wang Z et al. En bloc resection for intra-abdominal/retroperitoneal desmoid-type fibromatosis with adjacent organ involvement:a case series and literature review. Biosci Trends. 2018;12:620-6.
|
|
|
|
|
|
18) 高垣昌巳ほか.胸壁に発生したデスモイド腫瘍の1例.日胸臨.1994;53:769-73.
|
|
|
|
|
|
19) Fiore M et al. Desmoid-type fibromatosis:evolving treatment standards. Surg Oncol Clin N Am. 2016;25:803-26.
|
|
|
|
|
|
20) National Comprohensive Cancer Network:NCCN Guidelines:Rectal Cancer. 〈https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1461〉[Accessed Sep 22].
|
|
|
|
|
|
21) Yao X et al. A systemic review of active treatment option in patients with desmoid tumours. Curr Oncol. 2014;21:e613-29.
|
|
|
|
|
|
22) Fiore M et al. Hormoral manipulation with toremifene in sporadic desmoid-type fibromatosis. Eur J Cancer. 2015;51:2800-7.
|
|
|
|
|
|
23) Janinis J et al. The pharmacological treatment of aggressive fibromatosis:a systemic review. Ann Oncol. 2003;14:181-90.
|
|
|
|
|
|
24) Gounder MM et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med. 2018;379:2417-28.
|
|
|
|
|